4.7 Review

Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease

期刊

JOURNAL OF CLINICAL MEDICINE
卷 10, 期 13, 页码 -

出版社

MDPI
DOI: 10.3390/jcm10132910

关键词

non-invasive test; biomarker; fatty liver; liver fibrosis; non-alcoholic steatohepatitis

资金

  1. Innovative Medicines Initiative (IMI2) Program of the European Union [777377]
  2. European Union
  3. EFPIA
  4. Amsterdam UMC fellowship
  5. Health Holland TKI-public Private Partnership grants and researcg grants from Gilead

向作者/读者索取更多资源

In this study, FibroMeter versions were systematically reviewed for their performance in detecting different levels of fibrosis in patients with NAFLD. The findings indicated that FibroMeter VCTE had the highest diagnostic accuracy in detecting advanced fibrosis, followed by FibroMeter V2G and FibroMeter NAFLD, with no significant differences between the different versions. Head-to-head comparison studies are needed to further evaluate the performance of these tests.
Early detection of liver fibrosis is crucial to select the correct care path for patients with non-alcoholic fatty liver disease (NAFLD). Here, we systematically review the evidence on the performance of FibroMeter versions in detecting different levels of fibrosis in patients with NAFLD. We searched four databases (Medline, Embase, the Cochrane library, and Web of Science) to find studies that included adults with NAFLD and biopsy-confirmed fibrosis (F1 to F4), compared with any version of FibroMeter. Two independent researchers screened the references, collected the data, and assessed the methodological quality of the included studies. We used a bivariate logit-normal random effects model to produce meta-analyses. From 273 references, 12 studies were eligible for inclusion, encompassing data from 3425 patients. Meta-analyses of the accuracy in detecting advanced fibrosis (F >= 3) were conducted for FibroMeter Virus second generation (V2G), NAFLD, and vibration controlled transient elaFS3stography (VCTE). FibroMeter VCTE showed the best diagnostic accuracy in detecting advanced fibrosis (sensitivity: 83.5% (95%CI 0.58-0.94); specificity: 91.1% (95%CI 0.89-0.93)), followed by FibroMeter V2G (sensitivity: 83.1% (95%CI 0.73-0.90); specificity: 84.4% (95%CI 0.62-0.95)) and FibroMeter NAFLD (sensitivity: 71.7% (95%CI 0.63-0.79); specificity: 82.8% (95%CI 0.71-0.91)). No statistically significant differences were found between the different FibroMeter versions. FibroMeter tests showed acceptable sensitivity and specificity in detecting advanced fibrosis in patients with NAFLD, but an urge to conduct head-to-head comparison studies in patients with NAFLD of the different FibroMeter tests remains.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据